The global single molecule tracking market is estimated to be worth USD 1,039.5 million in 2024 and anticipated to reach a value of USD 1,775.6 million by 2034. Sales are projected to rise at a CAGR of 5.5% over the forecast period between 2024 and 2034. The revenue generated by single molecule tracking in 2023 was USD 985.3 million.
In order to investigate the biochemical behavior of individual endogenous protein molecules in cells, organs, and even entire organisms, a growing number of labs worldwide are using a variety of tracking techniques.
Single molecule tracking (SMT) has a wide range of uses in cell and molecular biology, including monitoring membrane receptor interactions and researching the translocation of molecular motors along the cytoskeleton. Every biological problem has unique obstacles and calls for a distinctive approach.
SMT methods have provided answers to a number of basic biological questions. These include exposing the mechanisms for selective cargo delivery through the nuclear pore complex and clarifying the motional mode of myosin V walking on the actin filament. These uses have helped the product become more popular, which has expanded its market.
Single Molecule Tracking Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 985.3 million |
| Estimated Size, 2024 | USD 1,039.5 million |
| Projected Size, 2034 | USD 1,775.6 million |
| Value-based CAGR (2024 to 2034) | 5.5% |
The single molecule tracking field has expanded across all areas of biological research over the last decade as a result of advancements in biological microscopy, genome editing, and fluorescence labeling technologies.
The SMT process allows visualization and tracking individual fluorescently labeled molecules in real time using the best estimating capability of imaging to observe molecular dynamics and interactions at the molecular scale.
Furthermore, the market is expanding with increasing interest in advanced imaging techniques for drug discovery, genomics, and personalized medicine. The high-resolution data observed at the molecular level with SMT technology is imperative to understanding complex biological processes, and thus it is an essential tool in biomedical research.
The advent of the light sheet and HILO illumination systems further expand the precision and the application of SMT for studying a new class of biophysical processes from the regulation of cell membranes to understanding nuclear dynamics in live cells.
As SMT technology continues to be adopted by the pharmaceutical industry, research institutions, and academic laboratories, the market will remain optimistic and likely continue upward.
The combination of single molecule tracking camera technology with CRISPR-based genome editing and advancements in artificial intelligence-based image analysis will potentially unlock new avenues for recreation and commercialization, ultimately securing single molecule tracking as an impactful and transformative tool in life sciences.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing Innovation in Florescent Technology Driving the Demand of Single Molecule Tracking
A pivotal stimulating force for the development of single molecule tracking (SMT) is sustained advancement of fluorescent tags and labeling technology. Next-generation fluorophores that are smaller, more vibrant, more photostable, and have less blinking, contribute to improved accuracy and reliability of SMT.
With these developments, researchers will be able to more accurately visualize and monitor individual molecules, leading to a better knowledge of cellular processes.
Furthermore, the market for fluorophores with a wide range of colour and fluorescence lifetimes is growing. The convenience of targeting multiple molecular species in the same cell, coupled with different lifetimes, valuable for multi-model tracking and examining molecular dynamics and interactions.
The additional benefit of being genetically encoded will further help bolster the overall use of these fluorophores in both basic and applied science, such as drug discovery and diagnostics.
Continual advancement of these technologies leads to better use of single molecule tracking devices or systems and eventually expansion of the SMT market; simply put, the increased diversity will stimulate a large spectrum of uses and purposes while also increasing efficiency in single molecule studies.
Rising Trend of 3D Imaging Techniques to Boost the Market
A prevailing direction of the single molecule tracking market is the transition towards three-dimensional (3D) imaging approaches and better signal-to-background (S/B) ratios.
Historically, single molecule tracking (SMT) particularly total internal reflection (TIRF) microscopy has been an imperative research strategy for studying biologically relevant molecular dynamic events at a surface or membrane; however, this work relies on the use of two-dimensional (2D) imaging condition. As a next step in investigating three-dimensional dynamics of single molecules, it has become increasingly more common to employ highly inclined and laminated optical sheet (HILO) microscopy, which extended the applicability of 2D SMT towards observing single molecules inside live cells, albeit with a less favorable S/B ratio.
To address these challenges faced in biological systems, the market is transitioning toward new and developing state-of-the-art methods that can provide more precise 3D tracking of molecules.
Advances in fluorescence microscopy methods such as light-sheet microscopy approaches and continued advanced HILO methods, have further earned knowledge for observing molecular processes in increasingly complex, thick and live tissue scenarios. Further developments in brighter, photostable fluorophores, and better detection capabilities will improve the quality of measurements, extend time/molecule observations, and measuring of molecular interactions in the 'live' frame of reference.
Collectively the aforementioned trends are yielding broader acceptance and use of SMT within the overall research community across diverse research areas, including the STEM fields of drug discovery, genomics and cellular biology, that continue to delve deeper into the investigations of biological system complexity.
Rising Drug Discovery and Protein Dynamics Research Bringing Opportunities in Single Molecule Tracking Services
The single molecule tracking market will experience significant growth, as more investments are made in drug discovery and protein dynamics research - areas that are vital to biomedical science and drug development, and where SMT will provide evidence of molecular interactions and behaviors across very high resolution.
In drug discovery, SMT can provide multi-dimensions of information about how prospective drug candidates interact with your intended molecular target. SMT can allow researchers to view the drug candidate interaction in real-time by tracking single molecules; how the compound itself interacts and binds to a protein, how the drug candidate molecular target itself may change conformations, and further observe any cellular effects that occur from that binding.
This level of detail will help shorten the timeframe and identify promising drug candidates by better understanding the drug action and produce an overall improved drug design through precise drug action effect outcomes and potential unintended off-target (i.e. additional) effects.
As the pharmaceutical industry continues to enter a future of personalized medicines, drug action, binding and broad multi-targeted interactions will become more critical for creating more targeted medication regimens. This future opens even greater needs of single cell tracking MS and the continuing needs to perform molecular interactions SMT MS.
In contrast and similar, the protein dynamics research area is important in single tracking protein behavior in dynamic interactions of proteins that dynamically function and move within cells. The ability to track these protein molecules into a closed and particular timeframe, will permit researchers to track and understand phenomena such as protein folding, protein conformations, or complex interactions with other molecular and cellular effectors of proteins.
These details will be critical to understanding diseases and interventions, with modulated and targeted interactions to either type of protein interaction in a new class of therapeutic guidelines.
In parallel, as drug discovery and protein dynamics research continue to focus on a microscope multi-dimensional molecular detail, the growth of SMT and increased investments in these areas is likely to help fuel the SMT market growth overall. There is considerable opportunity in the SMT market, largely driven by the need for more advanced and precise tools to in biological and medical research.
Dependency of Fluorescent Labeling Technologies is one of the Key Challenge in The Single Molecule Tracking
The SMT marketplace experiences various prohibiting factors associated with the constraints of their optical technologies, among which is the complex optical alignment that complicates operationally for devices that rely on using 4 -5 single-pixel detectors.
This alignment complexity results in complications maintaining highly accurate and reproducible measurements. These are technical issues that hamper SMT systems, equating to greater operational cost, as well as greater expertise and specialization requirements.
Additionally, the limited penetration depth of these imaging devices, primarily due to the one-photon excitation, restricts their effectiveness for single molecule observation deep within thick biological samples, such as tissues or entire intact organisms.
This limitation poses significant challenges for researchers, hindering the acquisition of detailed and rich observables in complex, heterogeneous, and multilayered samples, ultimately reducing the broader applicability and versatility of SMT to a wider range of scientific research and diagnostic applications.
Overall, these technological limitations inhibit the effectiveness and versatility of SMT technologies, and for broad uses and development, as a result presenting a challenge to SMT development and use in a broad penetration of scientific and medical applications.
The global single molecule tracking industry recorded a CAGR of 4.1% during the historical period between 2019 and 2023. The growth of single molecule tracking industry was positive as it reached a value of USD 985.3 million in 2023 from USD 799.2 million in 2019.
Over the past several decades, the market has changed dramatically. For the first decades of its existence, single-molecule techniques were only modestly sensitive, primarily using rudimentary fluorescence microscopy. In the early decade, the development of Total Internal Reflection Microscopy (TIRF) represented a pivotal point in which scientists were now able to use a microscope to view single molecules on surfaces with unprecedented localization precision.
After TIRF microscopy was introduced, more advanced dyes were developed, such as photoswitchable and photoactivatable dyes, which dramatically enhanced the scientist's ability to follow single molecules over time.
Once TIRF and advanced dyes had been incorporated into single molecule procedures, Electron-Multiplying CCDs (EMCCDs) were developed and provided significant increases in the reliability of data collected from single-molecule experiments.
At this time, the SMT market is functioning with several advanced technologies. While TIRF microscopy is somewhat commonplace in studies of molecules at surfaces, there are also relatively new techniques that have been used like Light-Sheet Microscopy and Highly Inclined and Laminated Optical Sheet (HILO) microscopy, both which allow for some 3D imaging and more favorable S/B ratio.
Also, fluorophores have been developed to be not only brighter but also more photostable; and the incorporation of AI has increased the capabilities and accuracy of modern SMT. All of these enhancements to single-molecule techniques allow for more rigorous studies of molecular dynamics in the context of more difficult interactions in complex biological systems.
Principal Consultant
Companies in the Tier 1 sector account for 66.1% of the global market, ranking them as the dominant players in the industry. Tier 1 players offer a wide range of advanced SMT systems for the for various applications including for academics, and have an established industry presence, offer continuous innovation. Prominent companies within Tier 1 include Leica Microsystems (Danaher Corporation), Nikon Corporation, Olympus Corporation, Carl Zeiss AG., and Thermo Fisher Scientific
Tier 2 players dominate the industry with a 24.2% market share. Tier 2 firms concentrate on its reputation for quality, regulatory compliance, and continuous innovation, combined with comprehensive support services and strategic partnerships. Tier 2 companies include eikon therapeutics, PerkinElmer, Inc., Horiba Ltd. and Others.
The section below covers the industry analysis for the single molecule tracking market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided.
The United States is anticipated to remain at the forefront in North America, with higher market share through 2034. In Asia Pacific, China is projected to witness a CAGR of 5.3% by 2034.
| Country | Value CAGR (2024 to 2034) |
|---|---|
| USA | 6.9% |
| UK | 6.1% |
| Spain | 5.7% |
| Germany | 5.4% |
| China | 5.3% |
USA single molecule tracking market is poised to exhibit a CAGR of 6.9% between 2024 and 2034. Currently, it holds the highest share in the North America market, and the trend is expected to continue during the forecast period.
The allocation of considerable funding for RNA research by the USA National Science Foundation is extraordinarily propelling the single molecule tracking SMT sector. Funds of more than USD 12.7 million to nine research teams of investigators, through the Molecular Foundations for Biotechnology (MFB) program, will stimulate research into RNA biotechnology applications.
The loans will support the development of new technologies and methodologies, including new applications to RNA biology, that all equally utilize high-resolution imaging modalities, such as SMT.
As research explores into RNA applications to disease prevention and cancer treatment, the need for reliable tracking of molecular behavior will ramp-up. The single molecule tracking (SMT) imaging modality will assist with real-time higher resolution imaging of RNA and tracking its complex molecular messages and dynamics.
Therefore, the investment in these biomedical platforms not only enhances innovation in the single molecule tracking imaging but also yields a strong need for advanced imaging technologies that support different imaging modalities using standard SMT technologies, thereby including SMT as a target technology supported by high-resolution imaging methodologies and RNA applications as pivotal agents in biotechnology.
UK single molecule tracking market is poised to exhibit a CAGR of 6.1% between 2024 and 2034. Currently, it holds the highest share in the Western Europe market, and the trend is expected to continue during the forecast period.
The life sciences sector in the UK has an estimated value of more than £94 billion, according to representatives of GOV.UK, and is a major contributor to the single molecule tracking market. In addition to the success of the life sciences sector, the UK government has recognized life sciences sector as a priority area, and the investment and regulation have focused on enabling innovation in this area.
The government has increased investment in the life sciences sector on critical projects, allowing researchers to conduct extensive research and applications using single molecule tracking methods to monitor molecular behaviors, interactions, and dynamics.
In addition, shifting government regulation and increased investment in the life sciences will provide an opportunity for market innovation and the development of advanced imaging technologies such as SMT.
This continued support will streamline the development and use of SMT methods in high priority areas of research in health and disease, including drug discovery and understanding of disease. Overall, the continued growth of the life sciences sector contributes to increased demand for more complex imaging solutions, including SMT technology, which ultimately drives growth and innovation in the market in the U.K.
China single molecule tracking market is poised to exhibit a CAGR of 5.3% between 2024 and 2034. Currently, it holds the highest share in the East Asia market, and the trend is expected to continue during the forecast period.
A significant force driving the single molecule tracking market in China is the country's strong commitment to investing heavily in biotechnology and other advanced and innovative scientific research. The Chinese government has prioritized biotechnology as a strategic area of national funding, and has made substantial investments in R&D, with the intention to develop the country's scientific capabilities and technological benefits.
There have been various initiatives and policies to improve the overall scientific infrastructure and foster high-tech industries such as recent announcement of "Made in China 2025" initiative, and national science and technology innovation policies.
These policies include generous financial support for research initiatives with promising technologies, development of high-end scientific instrumentation, and nods of support to cutting-edge research initiatives which will drive the demand for SMT technologies.
In addition, China's broadening political interests into personalized medicine and the discovery of pharmaceuticals and drugs compel the necessity for accurate and precise molecular single track imaging techniques that would allow researchers to determine the biological phenomena occurring at the level of single molecules.
Hence, we can infer the single molecule technology market in China will continue to expand due to the desire for better imaging technologies to support these policy-driven goals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section contains information about the leading segments in the industry. By technology, super-resolution microscopy holds the highest market share of 29.5% in 2024.
| By Technology | Super-Resolution Microscopy (SRM) |
|---|---|
| Value Share (2024) | 29.5% |
Being able to resolve molecular constructs at near-molecular scales provides more accurate and precise measurements of molecular positioning, motion, and interactions particularly crucial for studies of protein dynamics, intracellular signaling, and other essential biological systems.
While SRM can resolve molecular interactions in close proximity, it can also more accurately visualize complex and intricate phenomena such as receptor dimerization, protein folding, and DNA-protein interaction, also at near-molecular scales.
In summary, SRM's ability to deliver ultra-high resolution and detailed imaging makes it indispensable for SMT, as it enables the in-depth observation and precise tracking of single molecules, leading to more accurate, comprehensive, and insightful biological research.
This unique capability drives the adoption, innovation, and advancement of SMT technologies, solidifying SRM as a leading and foundational technology in the field.
| By End User | Academic and Research Institutions |
|---|---|
| Value Share (2024) | 53.4% |
Academic and research institutions are anticipated to be the leading end-users in the Single Molecule Tracking (SMT) market due to their strong focus on advancing scientific knowledge and studying complex biological processes. For SMT technologies, these institutions indicate demand for innovative research in the disciplines of molecular biology, genomics, and drug discovery.
With the scholarly mission to innovate and to discover, academic and research institutions receive significant funding and grant money, and can purchase sophisticated SMT systems. These research institutions provide the SMT market to leading edge scientific discoveries and methods, and can foresee continued growth and development in the field.
Academic and research institutions play a pivotal role in driving SMT advancements, significantly shaping the future of scientific research, technological innovation, and transformative breakthroughs across molecular biology, genomics, and drug discovery fields.
Leading companies in the single molecule tracking market are actively seeking partnerships and launching advanced products to strengthen their market position.
These strategic moves are aimed at enhancing technological capabilities, driving innovation, and meeting the growing demand for cutting-edge imaging solutions in research and biotechnology sectors.
Recent Industry Developments in Single Molecule Tracking Market
In terms of technology, the industry is divided into super-resolution microscopy, fluorescence microscopy and quantum dots.
In terms of application, the industry is segregated into drug discovery & development, molecular biology research, diagnostic applications, personalized medicine and others.
In terms of application, the industry is segregated into-academic and research institutions, pharmaceutical & biotech companies and others.
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, Middle East & Africa (MEA) have been covered in the report.
The global single molecule tracking market is projected to witness CAGR of 5.5% between 2024 and 2034.
The global single molecule tracking industry stood at USD 985.3 million in 2023.
The global single molecule tracking market is anticipated to reach USD 1,775.6 million by 2034 end.
USA is set to record the highest CAGR of 6.9% in the assessment period.
The key players operating in the global single molecule tracking market include Leica Microsystems (Danaher Corporation), Nikon Corporation, Olympus Corporation, Carl Zeiss AG., Thermo Fisher Scientific, eikon therapeutics, PerkinElmer, Inc., Horiba Ltd., Oxford Instruments and Andor Technology Ltd.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Technology 7.1. Super-Resolution Microscopy 7.2. Fluorescence Microscopy 7.3. Quantum Dots 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application 8.1. Drug Discovery & Development 8.2. Molecular Biology Research 8.3. Diagnostic Applications 8.4. Personalized Medicine 8.5. Others 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User 9.1. Research Institutes 9.2. Pharmaceutical & Biotech Companies 9.3. Others 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. East Asia 10.6. South Asia and Pacific 10.7. Middle East and Africa 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Sales Forecast 2024 to 2034 by Technology, Combination, Application, Packaging, Distribution Channel for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Leica Microsystems (Danaher Corporation) 20.2. Nikon Corporation 20.3. Olympus Corporation 20.4. Carl Zeiss AG 20.5. Thermo Fisher Scientific 20.6. eikon therapeutics 20.7. PerkinElmer, Inc. 20.8. Horiba Ltd. 20.9. Oxford Instruments 20.10. Andor Technology Ltd.
Explore Healthcare Insights
View Reports
Single Molecule Tracking Market
